Will a pharma-shaped pin burst the biotech bubble?
This article was originally published in Scrip
Executive Summary
This year, a combination of elements has combined to create a meteoric rise in biotech fortunes. But how long will it last? And will H2 see a reversal of riches? Andy Smith explores the inside of the biotech bubble.